Impact of the Implementation of a Clinical Pharmacy Bundle on Intensive Care Unit Patient Outcomes and Cost Expenditures

Completed

• Conditions: Intensive Care

• Registration Number: NCT02924844
• Lead Sponsor: Centre Hospitalier Universitaire de Nīmes

Brief Summary

The aim of this before-after study was to assess the impact of a clinical pharmacy bundle of care activities on patient outcomes (length of hospital stay as a primary endpoint) and cost expenditure in two French ICUs.

Detailed Description

Not available

Study Timeline

• Study Start: 2013-01
• Primary Completion: 2015-06
• Study Completion: 2015-06
• Status Verified: 2016-10
• Study First Submitted: 2016-10-04
• Study First Submitted QC: 2016-10-04
• Last Update Submitted: 2016-10-04
• Study First Posted: 2016-10-05
• Last Update Posted: 2016-10-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2787

Inclusion Criteria

• Intensive Care Unit patients on weekdays

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Length of hospital stay	expected average of 20 days

Secondary Outcome Measures

Name	Time	Method
Intensive Care Unit length of stay	Expected maximum of 10 days
Mechanical ventilation duration	Expected maximum of 10 days
Intensive care unit mortality rate	Expected maximum of 10 days
Hospital mortality rate	End of hospital stay (expected average of 20 days)
Patient cost expenditure	End of hospital stay (expected average of 20 days)